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Augmented arginine uptake, through modulation of cationic
amino acid transporter-1, increases GFR in diabetic rats.
Background. It is suggested that either arginine or its metabo-
lites, nitric oxide and polyamines play a role in the renal hemo-
dynamic alterations observed in the early stages of diabetes.
Yet, the regulation of arginine transport in diabetic kidneys has
never been studied.
Methods. Arginine uptake was determined in glomeruli har-
vested from control rats; diabetic rats (2 weeks following
an intraperitoneal injection of streptozotocin, 60 mg/kg body
weight); rats, 4 days following left nephrectomy (a nondiabetic
model of hyperfiltration); diabetes + lysine (0.5% in the drink-
ing water to attenuate arginine uptake); and control + lysine.
Results. Glomerular arginine transport was significantly in-
creased in diabetic rats, but remained unchanged following
uninephrectomy. Lysine abolished the increase in arginine up-
take in diabetic rats but had no effect in controls. The increase in
creatinine clearance observed in diabetes was completely abol-
ished by lysine. Using reverse transcription-polymerase chain
reaction (RT-PCR), Northern blotting, and immunohistochem-
istry, we found a significant increase in glomerular cationic
amino acid transporter-1 (CAT-1) expression in diabetic ani-
mals, which was unaffected by lysine. When human endothelial
cells were incubated with arginine end products no effect on
arginine transport was observed. However, only in the pres-
ence of 0.5mmol/L sodium nitroprusside (SNP) an augmented
steady-state CAT-1 mRNA was demonstrated by RT-PCR.
Conclusion. In a rat model of early diabetes, glomerular argi-
nine uptake is elevated through modulation of CAT-1 expres-
sion, thus, contributing to the pathogenesis of hyperfiltration.
Increased nitric oxide formation may play a role in this process.
Hyperfiltration secondary to renal vasodilatation is
characteristic of early diabetes [1]. Cumulative evidence
in the literature suggests that either arginine or its
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metabolites, namely, nitric oxide and polyamines play a
role in the renal hemodynamic alterations observed in the
early stages of diabetes. Excessive nitric oxide produc-
tion in diabetic animals was previously documented and
suggested to induce renal vasodilatation and increased
glomerular filtration rate (GFR) [2–4]. In contrast, argi-
nine administration prevented glomerular hyperfiltration
in diabetic rats [5], and inhibition of renal ornithine de-
carboxylase activity (the rate-limiting step in polyamines
biosynthesis) has been shown to prevent kidney hyper-
trophy in experimental diabetes [6]. Present knowledge
about regulation of arginine transport in diabetic kidneys
is fragmentary. Although renal tubular cells have the ca-
pacity to synthesize arginine, the cellular uptake route is
believed to be of major importance [7, 8].
In the kidney, L-arginine transport is mediated by the
y+ system carrier. Several transporters have been iden-
tified, and three transporters, termed cationic amino acid
transporter-1, -2, and -3 (CAT-1, CAT-2, and CAT-3) ex-
hibiting the y+ system properties have been cloned. Sys-
tem y+ is characterized by high affinity for cationic amino
acids, saturability, sodium independence, stimulation of
transport by substrate on the opposite (trans) side of the
membrane, and inhibition of transport by substrate on the
same (cis) side of the membrane [9–14]. CAT-1 is ubiqui-
tously expressed, and appears to have a greater capacity
than CAT-2 for transstimulation [15]. CAT-2 has been
initially detected in activated murine macrophages and
lymphocytes. CAT 2A, an alternately spliced transcript
of CAT-2, encodes a kinetically distinct low affinity trans-
porter, and is highly expressed in liver of adult rodents
[15, 16]. CAT-3 expression was found to be present in
adult brain and only recently in rat renal inner medullary
collecting duct [17–19]. We have recently demonstrated
that both glomerular and mesangial arginine transport
systems are sodium independent, subjected to cis inhi-
bition by lysine but not methionine, and constitutively
express the two major arginine transporters, CAT-1 and
CAT-2. These findings support the notion that arginine
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uptake in renal tissue occurs largely via y+ system and
that the above transporters play a major role in glomeru-
lar arginine traffic [20].
Our current experiments were designed to determine
the effect of early diabetes on glomerular arginine up-
take and on the expression of CAT-1 and CAT-2, and to
elucidate whether these changes relate to glomerular hy-
perfiltration. In addition, we aimed to relate the changes
observed in glomerular arginine transport in diabetes to
the end products of arginine metabolism, namely, nitric
oxide, agmatine, and polyamines.
METHODS
All animal experiments described in this study were
conducted in accord with the protocol approved by the
institutional committee on ethics in animal experiments.
Studies were performed using male Wistar rats weigh-
ing 200 to 250 g. Animals were made diabetic by admin-
istration of streptozotocin (65 mg/kg intraperitoneally)
(Sigma Chemical Co., St. Louis, MO, USA) suspended
in sodium citrate buffer (pH 4.2). Blood glucose levels
were determined using tail blood samples. Animals that
exhibited blood glucose levels above 300 mg/dL were in-
cluded in the studies. Diabetic rats were treated daily
with protamine zinc insulin (PZI) insulin 2 to 4 IU in
late afternoon in order to adjust blood glucose levels at
approximately 350 ± 50 mg/dL. Animals were allowed
free access to regular rat chow and tap water. Experi-
ments were performed 2 weeks following the administra-
tion of streptozotocin. Age-matched normal rats served
as controls. Subsequently, rats were segregated into five
groups: group 1, control, untreated rats; group 2, diabetes;
group 3, uninephrectomy, in which animals underwent
right nephrectomy and were allowed to recover 4 days, af-
ter which experiments were performed (this group served
as a nondiabetic model of glomerular hyperfiltration);
group 4, diabetes + lysine, in which diabetic rats were
given L-lysine 0.5% in drinking water (starting from day
1) in order to attenuate arginine uptake; and group 5, con-
trol + lysine, in which untreated rats were given lysine as
in group 4.
Measurement of GFR
Rats were anesthetized with Ketalar, 8 mg/100 g body
weight, and xylazine, 0.25 mg/100 g body weight, in-
traperitoneally. The animals were placed on a servo-
controlled heating table to maintain body temperature
at 37◦C. Tracheostomy was performed to facilitate free
breathing. The right femoral artery was cannulated to
obtain blood samples and monitor arterial pressure [HP
1290C Universal Quartz transducer (Tektronix, Inc.,
Beaverton, OR, USA) and a Mennen Med recorder
(Clarence, NY, USA)]. The right jugular vein was can-
nulated for the infusion of isotonic NaCl-NaHCO3 con-
taining 3 mg% creatinine. Maintenance solutions were
administered at a rate of 1.5 mL/hour. Additional solu-
tion was infused to match urinary flow rate. The bladder
was cannulated for urine collection. After completion of
the surgical preparation, the animals were allowed to sta-
bilize for 1 hour before clearance measurements were
initiated.
Renal clearance experiments were conducted during
three successive 20-minute periods. Arterial blood sam-
ples (160 lL) were withdrawn at the middle of each urine
collection period. Creatinine clearances were calculated
by standard equations.
Isolation of glomeruli
Additional animals were used for in vitro studies. Kid-
neys from all experimental groups were harvested, decap-
sulated, bisected, and the cortex was carefully dissected
free. Glomeruli were prepared using a sieving technique.
Cortices were minced to a fine paste with a razor blade
and gently pressed through a 106 lm stainless steel sieve.
The resulting material was suspended in HEPES buffer
(KCl 5 mmol/L, CaCl2 0.9 mmol/L, MgCl2 1 mmol/L,
D-glucose 5.6 mmol/L, HEPES 25 mmol/L, and NaCl
140 mmol/L), at 40◦C, pH 7.4. The suspension was forced
through a 20 gauge needle to decapsulate the glomeruli
and then passed through a 75 lm sieve. Glomeruli which
were trapped on the sieve were washed and pelleted by
centrifugation at 1000 rpm for 1 minute. This was re-
peated three times. This fraction consisted of more than
95% glomeruli, the majority of which were decapsulated.
The isolated glomeruli were used for RNA extraction and
for arginine uptake measurements.
L-arginine uptake by freshly harvested glomeruli
Arginine uptake was determined essentially as de-
scribed by Gazzola et al [21]. Glomerular suspensions
from the various experimental groups were incubated
and shaken for 10 minutes in HEPES buffer at pH 7.4,
37◦C. L-[H3] arginine and L-arginine, in a final concen-
tration of 1 mmol/L, were added to a total volume of
1 mL for additional 4 minutes. The duration of 4 min-
utes was chosen since it was within the linear portion
of uptake curves (data not shown). Transport activity
was terminated by rapidly washing the cells with ice-
cold phosphate-buffered saline (PBS) buffer (four times,
2 mL/tube). The glomeruli where then dried and solubi-
lized in 1 mL of 0.5% sodium dodecyl sulfate (SDS) in
0.5 N NaOH. Seven hundred microliters of the lysate
were used to monitor radioactivity, by liquid scintil-
lation spectrometry (Betamatic) (Kontron Instruments,
Trappes, France). The remaining 300 lL were used for
protein content determination by Lowry method. To
correct for nonspecific uptake or cell membrane bind-
ing, glomeruli were incubated with 10 mmol/L unla-
beled arginine in HEPES buffer, and the associated
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radioactivity was subtracted from each data point. Re-
sults are expressed as mean ± SE of at least five different
experiments.
L-arginine uptake in endothelial cells
Bone marrow–derived transformed endothelial cells
(a generous gift from A. Eldor, Hematology Depart-
ment, Tel Aviv Medical Center) were seeded onto 6-well
plates (Corning Incorporated, Corning, NY, USA), at a
density of 106 cells per well. When confluent, they were
washed with 2 mL HEPES buffer, 37◦C, pH 7.4. Sodium
nitroprusside (SNP), agmatine, or putrescine (all from
Sigma Chemical Co.), in varying concentrations (0.1 to
1 mmol/L), were added for 24 hours.
Cells were then washed and transport assay was per-
formed by adding, 1 mL of L-[H3] arginine and L-arginine,
in a final concentration of 1 mmol/L, for 1 minute (within
the linear portion of uptake curve). Transport assays were
performed as described above.
Analysis of mRNA levels for CAT-1 and CAT-2 by reverse
transcription-polymerase chain reaction (RT-PCR)
Total cellular RNA was extracted from glomeruli
or endothelial cells following the method described
by Chomeczynski and Sacchi [22]. RT was carried out
for 11/2 hours at 42◦C, and PCR in 10 × buffer for
a total of 35 cycles, each of 94◦C for 1 minute, 60◦C
for 1 minute, 72◦C for 2 minutes, and 7 minutes (final
cycle). The first pair of primers was designed to bind
to a portion of the rat CAT-1 gene: forward 21-mer,
5′-GCCATCGTCATCTCCTTCCTG-3′ and reverse 21-
mer, 5′-CCCTCCCTCACCGTATTTCAC-3′ expression.
A second pair of primers, which hybridize to a sequence,
common to both CAT-2 and CAT-2A were forward
24-mer, 5′-AACGTGCTTTTATGCCTTTGT-3′ and re-
verse 23-mer 5′-GGTGACCTGGGACTCGCTCTT-3′
[23]. A third pair of primers was designed to bind to
a portion of the human CAT-1 gene: forward 21-mer,
5′-CCAGTACTTCCGACGAGTTAGA-3′ and reverse
22-mer, 5′-CATCCACACAGCAAACCGGACC-3′.
The following pairs of primers were used for arginase
I: forward 25-mer, 5′-AAAGCCCATAGAGATTAT
CGGAGCG-3′, and reverse 22-mer, 5′-AGACAAG
GTCAACGGCACTGC C-3′; for arginase II: forward
23-mer, 5′-TTAGTAGAGCTGTGTCAGGTGGC-3′
and reverse 24-mer, 5′-ACTTGAAGCAATCACAT
CCACTGC-3′. To exclude the possibility of contamina-
tion by genomic DNA amplification, and to assess the
adequacy of cDNA, experiments were carried out in the
absence of reverse transcriptase.
Amplification of glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) was performed, respectively. PCR
products were electrophoresed on a 1.6% agarose gel and
visualized by ultraviolet-induced fluorescence. All PCR
reactions resulted in the amplification of a single product
of the predicted size for CAT-1, CAT-2/2A, arginase I,
arginase II, and GAPDH.
Northern blot analysis
CAT-1 mRNA level was determined by northern
hybridization. Fifteen micrograms of total RNA were de-
natured and fractionated by size on 1.3% formaldehyde-
agarose gel. RNA was transferred overnight, by capillary
action, to a nylon membrane (Hybond-N, Amersham In-
ternational, Buckinghamshire, UK), and cross-linked by
short-wave ultraviolet illumination. Purified end prod-
ucts of CAT-1 and GAPDH cDNA (High PureTM
PCR Product Purification Kit) (Boehringer Mannheim,
Mannheim, Germany) were used directly for radiolabel-
ing with [32P] deoxycytidimine triphosphate (dCTP) by a
random primer labeling method (Random Primers DNA
Labeling System Kit) (Gibco BRL, Gaithersburg, MD,
USA). After prehybridization for 1 hour at 50◦C, mem-
branes were hybridized overnight at 50◦C with the 32P-
labeled cDNA. Membranes were sequentially washed
twice in 1 × standard sodium citrate (SSC), 0.1% SDS
for 15 minutes, at room temperature, once in 1 × SSC,
0.1% SDS for 15 minutes at 50◦C, followed by 0.5 × SSC,
0.1% SDS at 55◦C for 30 minutes, and then washed at high
stringency in 0.1 × SSC, 0.1% SDS at 57◦C for 15 min-
utes. Autoradiography was carried out with Kodak XAR
film (Kodak, Rochester, NY, USA) for 24 to 48 hours
at −80◦C. Relative mRNA abundance was quantified by
measuring the density of the exposed film with a densito-
meter (B.I.S. 202D) (Fuji, Tokyo, Japan). CAT-1 mRNA
level was normalized to GAPDH mRNA and expressed
in arbitrary units as the ratio of CAT-1 to GAPDH ex-
pression in three different experiments.
Immunohistochemical analysis
For immunostaining, renal tissues were fixed in 4%
buffered formaldehyde for 24 hours and embedded in
Paraplast (Oxford Labware, St. Louis, MO, USA). The
paraffin blocks were cut and mounted on slides and pro-
cessed by labeled streptavidin-biotin method using His-
tostain Plus Kit (Zymed Laboratories, San Francisco,
CA, USA). Sections were then incubated for 30 min-
utes with 1:400 diluted rabbit polyclonal anti-CAT-1 an-
tibody (synthesized by Dr Leitner, Weizmann Institute,
Rehovot, Israel). A biotinylated secondary antibody was
applied for 10 minutes, followed by incubation with
horseradish peroxidase-conjugated streptavidin (HRP-
SA) for 10 minutes. Slides were washed thoroughly with
Optimax wash buffer (Biogenex, San Ramon, CA, USA)
following each incubation. The immunoreaction was vi-
sualized by an HRP-based chromogen/substrate system
(Liquid DAB Substrate Kit) (Zymed). Sections were then
counterstained with Mayer’s hematoxylin, dehydrated in
ascending ethanol concentrations, cleared in xylene, and
mounted for microscopic examination.
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Fig. 1. Effects of glomerular arginine uptake in diabeti rats. (A)
Sodium independence and cis-inhibition by lysine. Uptake of radio-
labeled arginine ([3H] L-arginine) by freshly harvested glomeruli from
diabetic animals in the presence of either 140 mmol/L sodium chlo-
ride (Na) or 140 mmol/L choline chloride and lysine or methionine
10 mmol/L. Data are presented as the mean ± SEM of four different
experiments. ∗P < 0.05 vs. control. (B) Concentration dependence of L-
arginine. Uptake of [3H]-arginine was measured for 4 minutes in freshly
harvested glomeruli from diabetic rats over a range of concentrations (0
to 1 mmol/L). Data are presented as the mean ± SEM of four different
experiments.
Statistical analysis
Means ± SE one-way analysis of variance (ANOVA)
for comparison between groups and Student t test be-
tween two groups were computed and used to assess sta-
tistical significance. P values < 0.05 were considered to
be statistically significant.
RESULTS
Initially, we wished to explore the possibility that early
diabetes changes the characteristics of y+ system, the pre-
dominant arginine uptake system in glomeruli. Figure 1A
demonstrates that in glomeruli harvested from diabetic
animals arginine transport system remains sodium in-
dependent. Excess concentration of lysine strongly in-
hibited L-arginine uptake while the neutral amino acid
methionine was found to be a poor inhibitor. In addition,
we characterized the kinetics of L-arginine transport in
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Fig. 2. Uptake of radiolabeled arginine ([3H] L-arginine) by freshly
harvested glomeruli. (A) Uptake from controls (CTL), diabetes (D),
uninephrectomy (Neph), diabetes + lysine (D + L), and control + ly-
sine (CTL + L). Data are presented as the mean ± SEM of at least five
different experiments. ∗P < 0.05 vs control. (B) Uptake from diabetic
rats pretreated with different concentrations of lysine in the drinking
water. Data are presented as the mean ± SEM of four different exper-
iments ∗P < 0.05 vs. control.
diabetic glomeruli by measuring saturable uptake of L-
arginine (0 to 1 mmol/L). The plot of L-arginine uptake
as a function of extracellular L-arginine concentration is
shown in Figure 1. A high affinity transporter was found
to be present with a Km of 135 lmol/L and Vmax of
14.5 nmol arginine/lg protein/4 minutes. These data es-
tablish that in glomeruli from diabetic rats system y+ re-
mains the predominant arginine transport system and the
kinetic properties of the system resemble those of CAT-1
and CAT-2.
The next set of experiments was designed to explore
a possible effect of diabetes on glomerular y+ system.
When compared to normal rats, diabetes induced a sig-
nificant increase in glomerular arginine uptake. In con-
trast, we found that arginine traffic in rats subjected to
uninephroctomy, a different model of glomerular hyper-
filtration, remained unchanged (Fig. 2A). In order to
study a possible relation between glomerular arginine
transport and hyperfiltration, we performed experiments
Schwartz et al: Augmented argaine uptake increases GFR in diabetic rats 1315
1.4
1.2
1
0.8
0.6
0.4
0.2
0
CTL CTL + L D D + L
Cr
 C
l, 
m
L/
m
in
/1
00
 g
 B
W
Fig. 3. Glomerular filtration rate (GFR) indexed by creatinine clear-
ance, in controls (CTL), control + lysine (C + L 0.5%), diabetic (D),
and diabetes + lysine (D + L 0.5%) (N = 6). Results shown are mean
± SEM. ∗P < 0.05 vs. controls.
in which lysine (a competitive inhibitor of arginine uptake
by the y+ system) was added to the drinking water of
diabetic animals. Three different concentrations were
used (0.1, 0.5, and 1%) Diabetic rats given 0.5% lysine
in water had arginine uptake rates comparable to con-
trols. Using the same concentration of lysine did not affect
arginine uptake in control animals (Fig. 2B). Creatinine
clearance was then measured in the same experimental
groups.
Diabetes resulted in a significant increase in creati-
nine clearance (1.05 ± 0.07 mL/min/100 g body weight vs.
0.55 ± 0.05 mL/min/100 g body weight, P < 0.01). The ad-
ministration of L-lysine (0.5%) significantly attenuated
the increase in creatinine clearance in diabetic animals
while it had no effect in control rats (0.50 ± 0.09 mL/
min/100 g body weight and 0.42 ± 0.08 mL/min/100 g
body weight, respectively) (Fig. 3).
Regulation of CAT-1 and CAT-2 gene expression
in diabetes
To determine whether the observed diabetes-induced
changes in arginine uptake are associated with similar
directional changes in mRNA levels for CAT family of
transporters, total glomerular RNA was analyzed by RT-
coupled PCR to amplify portions of CAT-1 and CAT-2.
We identified cDNA encoding both CAT-1 and CAT-2 in
glomeruli harvested from control rats. Diabetes signifi-
cantly augmented the expression of CAT-1 mRNA while
CAT-2 remained unchanged (Fig. 4). To further con-
firm this observation, Northern blotting was performed
(Fig. 5). Diabetic rats exhibited a significant increase
in steady-state glomerular CAT-1 mRNA level, which
was unaffected by cotreatment with lysine (0.5%) in the
drinking water. Lysine had no effect on glomerular CAT-1
mRNA in control rats.
CAT-2
CAT-1
GAPDH
613 bp
531 bp
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Control Diabetes
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CAT-1
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1.4
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Fig. 4. Cationic amino acid transporter-1 (CAT-1), CAT-2, and
glyceraldehyde-3 phosphate dehydrogenase (GAPDH) cDNA of
glomeruli. (A) Ethidium-stained agarose electrophoresis gel showing
polymerase chain reaction (PCR)-amplified cDNA harvested from con-
trol (CTL) and diabetic (D) rats. These blots are representative of three
different experiments. See text for definition of groups. (B) Relative
amount of CAT-1 and CAT-2 mRNA quantitated by densitometry and
expressed as CAT/GAPDH ratio of the same experiments shown in (A).
Data are presented as the mean ± SEM of three different experiments.
∗P < 0.05 vs. control.
Glomerular CAT-1 protein in diabetes
Immunohistochemical analysis with an anti-CAT-1 an-
tibody was performed to elucidate the extent of CAT-1
protein in kidneys taken from our experimental groups.
Figure 6 depicts a dramatically augmented staining in di-
abetes, predominantly detected in glomerular capillary
endothelial cells. Similar findings were obtained in lysine-
treated diabetic animals.
Effect of early diabetes on arginase I and arginase II
mRNA expression
RT-PCR was utilized to examine the changes in
arginase I and II in early stages of diabetes. The expres-
sion for both isoenzymes was significantly increased as
compared to controls (Fig. 7).
Effect of L-arginine metabolites on CAT-1 mRNA
Since all three arginine metabolites-nitric oxide, ag-
matine, and polyamines have a potential for both
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Fig. 5. Effect of diabetes on steady-state cationic amino acid
transporter-1 (CAT-1) mRNA in rat glomeruli. (A) Northern blot anal-
ysis of glomerular CAT-1 and glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) mRNA from all experimental groups. These blots are
representative of three different experiments. Abbreviations are: CTL,
control; CTL + L, normal rats treated with lysine; D, diabetic rats; D +
L, diabetic rats treated with lysine. (B) Graphic representation of rela-
tive changes in mRNA levels. The ratio of the signal of the 7.9 kb CAT-1
mRNA over the signal of GAPDH mRNA was plotted against the ap-
propriate experimental group. ∗P < 0.05 vs. control (mean ± SEM of
three different experiments).
augmenting GFR and altering arginine uptake, we tested
the effect of these substances on arginine uptake and
CAT expression in endothelial cells. Incubating cells with
increasing concentrations of either SNP, agmatine, or pu-
trescine (0.1 to 1 mmol/L) had no effect on arginine up-
take (data not shown). However, analyzing the level of
CAT-1 mRNA in endothelial cells by RT-PCR revealed
that 0.5 mmol/L of SNP induced a significant increase
in CAT-1 expression while no effect was obtained with
similar concentrations of either putrescine or agmatine
(Fig. 8).
DISCUSSION
The current studies were designed to determine
whether glomerular arginine transport is modulated in
the early stages of diabetes and to define a possible conse-
quent impact upon glomerular function. Three principal
issues were addressed: (1) whether arginine uptake is al-
tered in the diabetic kidney, and by which transporter/s,
(2) do changes in arginine uptake observed in diabetes
bear relationship to glomerular hyperfiltration, and (3)
to try and define a possible mechanism.
We have demonstrated that diabetic rats exhibit aug-
mented glomerular arginine uptake with characteris-
tics corresponding to the y+ system. This phenomenon
was associated with modulation of both CAT-1 mRNA
and protein. In order to determine whether changes in
glomerular filtration have a potential to affect arginine
uptake, we measured arginine transport in rats subjected
to uninephrectomy, as a different model of hyperfiltra-
tion. These animals exhibited normal arginine uptake, im-
plying that increased intracellular arginine requirements
are not essential for the development of hyperfiltration.
Next, we wished to examine whether this latter finding
plays a specific role in the pathogenesis of hyperfiltra-
tion in the early stage of diabetic nephropathy. Diabetic
rats were given lysine in the drinking water in order to
chronically attenuate arginine consumption by cells. We
have chosen to use lysine instead of an arginine analogue
to avoid any possible effect of such a substance on nitric
oxide synthase (NOS) enzymes. Attenuating arginine up-
take by chronic in vivo administration of lysine prevented
the hyperfiltration in diabetic rats. These findings sup-
port the postulate that the increase in arginine uptake,
observed in diabetes is related to glomerular function.
Interestingly, the effect of lysine was not associated
with prevention of CAT-1 up-regulation, implying that
augmentation of glomerular arginine uptake in diabetes
is a primary event and is not a result of changes in
glomerular hemodynamics. Indeed, increased arginine
uptake by other tissues in diabetes has been reported
previously.
Contreras et al [24] demonstrated that diabetes stim-
ulates arginine transport in isolated rabbit gastric glands
and Sobrevia et al [25], have shown that gestational di-
abetes is associated with activation of system y+ in hu-
man endothelial cells. To further consolidate our main
findings, we studied the expression of arginase I and II,
which activity may diminish intracellular arginine avail-
ability through metabolizing L-arginine into L-ornithine
and urea. Up-regulation of these isoforms was suggested
as a mechanism to prevent overproduction of nitric oxide
[26]. We found increased expression of both isoforms sup-
porting the observation of augmented intracellular argi-
nine content in early diabetes.
Our data suggest that (1) early diabetes augments argi-
nine uptake via modulation of CAT-1 and (2) increased
glomerular arginine traffic by CAT-1 impacts glomerular
hemodynamics. In contrast, Reyes et al [5], have shown
that arginine administration ameliorated the develop-
ment of hyperfiltration and proteinuria in diabetic rats.
Their findings contradict our conclusions since provid-
ing excess arginine to diabetic glomeruli cannot be im-
plicated in both enhancing and preventing glomerular
hyperfiltration. These discrepancies may well reflect
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Fig. 6. Immunostaining for cationic amino acid transporter-1 (CAT-1) protein. Glomeruli from control rats (A), rats treated with lysine (B), diabetic
rats (C), and diabetic rats treated with lysine (D) (details of the protocol are described in the Methods section). CAT-1 staining was increased in
the capillary endothelial cells of diabetic rats either treated or not treated with lysine.
different phases of the disease: While we studied animals
that were diabetic for only 2 weeks, their rats were kept
for 14 weeks before experiments were performed. Al-
ternatively, increased arginine uptake via modulation of
a specific transporter, as found here, could alter intra-
cellular arginine metabolism in a different manner than
merely the effect of excess extracellular arginine.
The effect of early diabetes on arginine transport was
largely mediated by modulation of CAT-1 expression.
Could this finding enlighten us about the role of argi-
nine in diabetic hyperfiltration? It has recently been ap-
preciated, at least with regard to nitric oxide generation,
that each arginine transporter serves a different NOS iso-
form. We have confirmed and extended these findings by
demonstrating that in both sepsis and ischemic acute re-
nal failure the induction of intact NOS (iNOS) is accom-
panied by up-regulation of CAT-2 [20, 27]. Furthermore,
B
D
Nicholson et al [28] have recently reported that iNOS
activity was reduced in macrophages from CAT-2 knock-
out mice. Taken together, one can assume that CAT-2 is
the source of intracellular arginine, which is consumed by
iNOS. CAT-1, on the other hand, has recently been shown
to colocalize with endothelial NOS (eNOS) in the cave-
olar complex [29]. Such a complex has been suggested to
serve as a mechanism for channeling of newly acquired
extracellular arginine to eNOS for nitric oxide synthesis.
Having illustrated CAT-1 protein to be almost restricted
to the capillary endothelium lends additional support to
this assumption. To our knowledge, these findings pro-
vide the first evidence that CAT-1 can be up-regulated in
vivo. This leads us to speculate that excess arginine pro-
vided by CAT-1 in early diabetes is being used to increase
activation of glomerular eNOS. Indeed, the increase in
L-arginine uptake, observed in human umbilical vein
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Fig. 7. Evaluations of arginase-1, arginase-2, and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) cDNA. (A) Ethidium-stained
agarose electrophoresis gel showing polymerase chain reaction (PCR)-
amplified from freshly harvested glomeruli of control and diabetic rats.
(B) Relative amount of arginase-1 and arginase-2 mRNA quantitated
by densitometry and expressed as arginase/GAPDH ratio of the same
experiments shown in (A). Data are presented as the mean ± SEM of
three different experiments. ∗P < 0.05 vs. control.
endothelial cells from patients with gestational diabetes,
is inhibited by blocking NOS [25].
The possible role of nitric oxide in diabetic hyperfiltra-
tion was dealt in depth by numerous papers and further
discussion is beyond the scope of the present study. In
brief, high urinary levels of NO2/NO3 and an exagger-
ated renal hemodynamic response to NOS antagonists
were interpreted to reflect excessive nitric oxide gener-
ation, which results in diabetic hyperfiltration [2–4]. In
contrast, decreased ex vivo generation of nitric oxide by
glomeruli harvested from diabetic rats has been reported
[30]. In addition, data regarding expression of various
NOS isoforms is confusing [31, 32].
Nevertheless, it is always tempting to relate the hemo-
dynamic changes in diabetes to nitric oxide. If increased
glomerular arginine uptake in diabetes reflects a greater
demand for the substrate by NOS, one could then
speculate that increased nitric oxide generation would
up-regulate CAT-1 in order to meet the increasing re-
quirements for substrate. To test this hypothesis, we
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Fig. 8. Cationic amino acid transporter-1 (CAT-1), CAT-2, and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA. (A)
Ethidium-stained agarose electrophoresis gel showing polymerase
chain reaction (PCR)-amplified CAT-1, CAT-2, and GAPDH of bone
marrow–derived transformed endothelial cells preincubated with ag-
matine, putrecine or sodium nitroprusside (SNP) (0.5 mmol/L) for
24 hours. Abbreviations are: CTL, control; Ag, agmatine; Putr, pu-
trecine. (B) Relative amount of CAT-1 and CAT-2 mRNA quantitated
by densitometry and expressed as CAT/GAPDH ratio of the same ex-
periments shown in Figure 6A. Data are presented as the mean ± SEM
of three different experiments. ∗P < 0.05 vs. control.
have incubated endothelial cells with increasing SNP,
a spontaneous nitric oxide donor, as well as with two
other arginine metabolites previously suggested to aug-
ment GFR: agmatine and putrescine (a representative of
the polyamine family). None affected arginine transport
velocity. Only SNP induced a significant increase in CAT-
1 mRNA expression when administered in supraphysio-
logic concentrations. Therefore, at this juncture we are
unable to provide solid evidence to support the hypoth-
esis that arginine uptake is increased to compensate for
increased nitric oxide generation. A plausible interpreta-
tion of our findings views the increase in renal arginine
uptake as an effect of diabetes on amino acid metabolism,
resulting in undesired augmented nitric oxide genera-
tion, causing impaired renal hemodynamics. Alterna-
tively, arginine could induce hyperfiltration via a nitric
oxide-independent mechanism yet to be discovered. Pos-
sible mechanisms could involve protein kinase C (PKC),
which is activated in diabetes. Both PKC and CAT-1 are
located in the caveola. CAT-1 protein contains three pu-
tative sites for phosphorylation by PKC. Recently, Kro-
tora, Zharikov, and Block [33] demonstrated that classi-
cal isoforms of PKC are involved in regulation of CAT-1
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transport activity in pulmonary artey endothelial cells by
altering the phosphorylation state of the transporter. Al-
ternatively, Flores et al [34] have shown that D-glucose in-
fusion activates arginine uptake in human umbilical vein
endothelial cells, an effect which was mediated by stimu-
lation of p42 and p44 mitogen-activated protein kinases
[34].
CONCLUSION
Arginine uptake is increased in glomeruli of diabetic
rats due to modulation of CAT-1 mRNA and protein and
might play a role in the pathogenesis of hyperfiltration
in the early stages of the disease. Increased nitric oxide
formation may have a contributing role in this process.
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